A novel, hydrogen sulfide-releasing mesalamine derivative (ATB-429) exhibits enhanced anti-inflammatory and analgesic activity in experimental colitis

被引：0
|
作者：
Wallace, P.
Distrutti, E.
Cirino, G.
Fiorucci, S.
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Perugia, I-06100 Perugia, Italy
[3] Univ Naples, Naples, Italy
来源：
INFLAMMATORY BOWEL DISEASES | 2007年 / 13卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：645 / 645
页数：1
相关论文
共 40 条
  • [1] Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis
    Fiorucci, S.
    Orlandi, S.
    Mencarelli, A.
    Caliendo, G.
    Santagada, V.
    Distrutti, E.
    Santucci, L.
    Cirino, G.
    Wallace, J. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (08) : 996 - 1002
  • [2] A hydrogen-sulfide releasing derivative of mesalamine exhibits markedly enhanced anti-inflammatory effects in experimental colitis
    Wallace, John L.
    Santucci, Luca
    Orlandi, Stefano
    Mencarelli, Andrea
    Distrutti, Eleonora
    Fiorucci, Stefano
    FASEB JOURNAL, 2007, 21 (05): : A131 - A131
  • [3] Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids
    Costa, Soraia K. P. F.
    Muscara, Marcelo N.
    Allain, Thibault
    Dallazen, Jorge
    Gonzaga, Larissa
    Buret, Andre G.
    Vaughan, David J.
    Fowler, Christopher J.
    de Nucci, Gilberto
    Wallace, John L.
    ANTIOXIDANTS & REDOX SIGNALING, 2020, 33 (14) : 1003 - 1009
  • [4] Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer
    Elsheikh, Wagdi
    Blackler, Rory W.
    Flannigan, Kyle L.
    Wallace, John L.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2014, 41 : 131 - 137
  • [5] Hydrogen sulfide-releasing anti-inflammatory drugs
    Wallace, John L.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (10) : 501 - 505
  • [6] Enhanced anti-inflammatory activity of hydrogen sulfide releasing derivative of mesalamine in rodent models of colitis, involves direct inhibition of Nf-κB
    Fiorucci, Stefano
    Distrutti, Eleonora
    Mencarelli, Andrea
    Renga, Barbara
    Cirino, Giuseppe
    Wallace, John L.
    GASTROENTEROLOGY, 2006, 130 (04) : A348 - A349
  • [7] Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat
    Wallace, John L.
    Caliendo, Giuseppe
    Santagada, Vincenzo
    Cirino, Giuseppe
    Fiorucci, Stefano
    GASTROENTEROLOGY, 2007, 132 (01) : 261 - 271
  • [8] PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346)
    Wallace, John
    Buret, Andre
    Nagy, Peter
    Muscara, Marcelo
    de Nucci, Gilberto
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 522 - 522
  • [9] Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer
    Ianaro, Angela
    Cirino, Giuseppe
    Wallace, John L.
    PHARMACOLOGICAL RESEARCH, 2016, 111 : 652 - 658
  • [10] ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo
    De Cicco, Paola
    Panza, Elisabetta
    Ercolano, Giuseppe
    Armogida, Chiara
    Sessa, Giuseppe
    Pirozzi, Giuseppe
    Cirino, Giuseppe
    Wallace, John L.
    Ianaro, Angela
    PHARMACOLOGICAL RESEARCH, 2016, 114 : 67 - 73
1234